from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2669/-

LFCtreatmentdescriptionclass of inhibitor

0.545

Amikacinug/mL Amikacintranslation

0.284

Cap5-10ug/mL Capreomycintranslation

0.886

Rox10-50 ug/mL Roxithromycintranslation

1.200

SM2-5 ug/mL Streptomycintranslation

-0.829

Tet5-10 ug/mL Tetracyclinetranslation

0.568

Rif0.2-5ug/mL Rifampicintranscription

-0.060

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.898

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.066

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.736

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.317

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.250

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.541

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.287

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.716

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.243

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.114

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.624

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.998

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.520

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.736

Nigericin50 uM Nigericinrespiration

-0.030

TRC10-150 ug/mL Triclosanrespiration

1.043

TRZ10-25 ug/mL Thioridazinerespiration

3.576

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.783

menadione6-10 ug/mL Menadionerespiration

-0.261

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.093

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.082

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.261

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.216

NRP_1Non-replicating persistence stage 1dosRassociated

-0.125

Amp0.2mg/mL AmpicillincellWall

-0.577

Cephalexin20-100 ug/mL CephalexincellWall

-0.174

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.226

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.379

EMB10-20 ug/mL EthambutolcellWall

0.512

Eta12-40 ug/mL EthionamidecellWall

-0.271

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.307

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.075

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.488

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.001

BZA0.12 mg/mL BenzamidearomaticAmides

0.235

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.262

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.015

H2O24 mM hydrogen peroxideDNAdamaging

-0.103

Levo10 ug/mL LevofloxacinDNAdamaging

-0.219

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.371

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.192

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.578

UVUV-irradiationDNAdamaging

-0.748

ARP41-4 ug/mL Antitubercular compound ARP4?

0.156

Antimycin12.5-50 ug/mL Antimycin A?

-0.294

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.370

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.195

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.874

PA8240.2-2 ug/mL PA-824?

-0.012

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.266

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.307

Verapamil50 uM Verapamil?

-0.142

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.188

methoxatin10-20 ug/mL Methoxatin?